Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

LeadDesk’s strong growth continues during the first quarter

LeadDesk Plc Press Release 28/4/2022 at 9.35LeadDesk Plc Business review 1/1–31/3/2022 Unofficial translation of company release 28 April 2022, 9:30 am. In case the document differs from the original, the Finnish version prevails. Figures in parenthesis refer to the equivalent period in the previous year, unless otherwise stated. Figures presented in this business review are unaudited.  In addition to the Financial statements and the Half year review, starting from 2022 LeadDesk will publish abbreviated business reviews for January–March and July–September. January–March 2022

Interim report Q1/2022: Our financial targets remain in place

Significant Significant events after the quarterevents inQ1 · In · In April, Enzymatica announced that its mouth spray would beMarch, launched in Turkey by its partner Sanofi in 2022. The productEnzymatica will be sold under one of Sanofi’s own brands.announcedthat itsmouth spraywould belaunched inMexico byits partnerSanofi in2022. Theproductwill besold underone ofSanofi’sown brands.   Other events  during thequarter · In January,Enzymatica’spartner STADAtook overresponsibilityin Denmark,Norway and

HKScan publishes its January-March Interim Report on 10 May 2022

HKScan Corporation, media release 28 April 2022HKScan Corporation publishes its January-March Interim Report on 10 May 2022 at about 8.30 a.m. EET. CEO Tero Hemmilä’s video review will be available at www.hkscan.com.  Investor calls will be arranged upon requests. Kindly contact Heidi Hirvonen, heidi.hirvonen@hkscan.com or tel. +358 10 570 6072 to make an appointment. HKScan Corporation Heidi HirvonenSVP Communications  For further information:HKScan Media Service Desk tel. +358 10 570 5700 or email communications@hkscan.com

News conference on Kojamo’s Interim Report for January–March 2022 on 12 May 2022

Kojamo plc Press Release, 28 April 2022 at 9:30 a.m. EESTNews conference on Kojamo’s Interim Report for January–March 2022 on 12 May 2022 Kojamo plc’s Interim Report for January–March 2022 will be published on Thursday, 12 May 2022 at approximately 8:00 a.m. EEST. News conference and webcast Kojamo will hold a news conference for institutional investors, analysts and media on 12 May 2022 at 10:00 a.m. at its headquarters at Mannerheimintie 168A, Helsinki, Finland. The event will be hosted by Kojamo’s CEO Jani Nieminen and CFO Erik Hjelt, and it will be held in English. After the

AcouSort places a modified AcouWash at Lund University to support cancer research

AcouSort has placed an AcouWash at Lund University. The system is modified to perform separation of circulating tumor cells (CTCs) from white blood cells. The modified AcouWash is similar to the system that was sold to Umeå University in 2020 and will be used in a clinical study comparing different methods for discovering CTCs in patient samples.The AcouWash placed at Lund University has been modified to enable separation of circulating tumor cells (CTC) from white blood cells. The goal for Lund University’s research group is to use the modified AcouWash in a clinical study, benchmarking it

Interim report January to March 2022

Press release, Sweden, Stockholm, April 28, 2022 Improved market climate but disturbances in the supply chain affecting volume and margin First quarter 2022 · Net sales increased during the first quarter by 6,9% to 79,5 MSEK (74,4). Currency translations had a positive effect of 5,0 MSEK on net sales. · Adjusted EBITDA decreased during the first quarter by 109,5% to -0,9 MSEK (9,9), corresponding to an adjusted EBITDA margin by -1,2 % (13,3) · Operating profit/loss was -7,9 MSEK (4,8) which correspond to operating margin of -9,9% (6,5) · Profit for the quarter was -8,6

XMReality Interim report, Group overview, January–March 2022

Order backlog increased with 10 percent compared with the same quarter last year, Net sales decreased with 16 percent and the Gross margin increased from 90 to 94 percent.January – March 2022, The Group · Net sales amounted to SEK 4,810 thousand (5,757) · Costs totaled SEK -16,593 thousand (-12,518) · The operating loss before appropriations and taxes was SEK -10,789 thousand (-6,257) · Cash flow for the period was SEK -9,040 thousand (50,416) and the equity/assets ratio at the end of the period was 65.0 (81.7) percent Net sales decreased with 16 percent to SEK 4,810

Prevas interim report January – March 2022

Solid start of the year. January – March 2022 · Net turnover 315.6 MSEK (300.9) · Operating profit/loss EBITA 44.2 MSEK (31.6) · Operating margin EBITA 14.0% (10.5) · Profit after tax 31.7 MSEK (22.9) · Profit per share before dilution 2.47 SEK (1.75) A word from the CEO Stable and strong development. Reassuring start The start of 2022 has been truly strong. Good margin, increased sales, increase in the number of employees and intensive work with acquisitions. Sales landed at SEK 316 million (301). EBITA was SEK 44.2 million (31.6). The EBITA margin in

MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2022

Momentum in several areas, not least the development of our cutting-edge project fostroxacitabine bralpamide January – MarchFinancial summary for the quarter · Net turnover amounted to SEK 0.5 (9.9) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -31.4 (-7.2) million. Basic and diluted earnings per share amounted to SEK -0.59 (-0.18) and SEK -0.59 (-0.18) respectively. · Cash flow from operating activities amounted to SEK -39.9 (-1.5) million. · Cash and cash equivalents at the end of the period amounted to SEK 180.8 (269.3)

INVITATION: INVISIO invites you to a conference call May 5 at 10:00 CEST

INVISIO is pleased to invite press, investors and analysts to a conference call on May 5 at 10.00 CEST where CEO Lars Højgård Hansen will present the Interim Report January-March 2022.The conference call, which will be held in English, will begin with a presentation of the report followed by a Q&A session. The report will be published on May 4, 2022, at 11:00 CEST.Phone number for the conference:To participate in the conference call, use the dial-in numbers below. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.Standard

Improved business mix and continued stable gross margin development during the quarter

Sales for PowerCell Sweden AB amounted to SEK 30.0m for the first quarter 2022 compared to SEK 29.7m the same quarter last year. Operating income at SEK -28.6m  (-23.9) was impacted by investments in sales and marketing. Gross margin for the quarter was 32.8% (32.4), following a continued stable development.The English version is an in house-translation. In case of any discrepancy, the Swedish text will prevail. The first quarter 2022 saw an increased interest in hydrogen-electric solutions with a greater proportion of total sales being generated by a growing number of customers in

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 27th April 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,775,037 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Transcom Holding AB (publ): Invitation to Transcom first quarter 2022 results presentation webcast

Transcom are pleased to invite you to their Q1 2022 financial update webcast on Thursday, May 12, at 9:00 am CET, following the release of Q1 2022 results at 8:00 am CET. The Q1 report and presentation will be available on https://www.transcom.com/global/about-us/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Snejana Koleva, CFO Presentation details Date/Time: Thursday, May 12, at 9:00 am CET Online Registration link: https://app.livestorm.co/transcom-holding/transcom-holding-ab-q1-2022-results-presentation Important note: Please register via

AirForestry gets permission to fly outdoors with its large drone - The Swedish Transport Agency gives the green light.

AirForestry has reached a crucial milestone, and is now able to test its drone system outdoors, where it will be used to thin out trees from the air. The Swedish Transport Agency has issued a permit for the company to fly its large drone at its test arena east of Uppsala. With self developed drones that are able to thin out trees from the air, AirForestry wants to pave the way for new gentle and sustainable methods of caring for and managing the forest. The company's large harvestingdrone measures 6.2 metres and is being developed to thin out forests. A key element for the company was

Atria's carbon footprint-labelled chicken products were awarded in an international innovation competition

Atria's chicken products, which have a carbon footprint labelling on their packaging, have been awarded in a innovation competition organized by the European Cooperative Society Cogeca. The prize for significant innovation was awarded in the “Traceability and Consumer Information” series. The award was presented in Brussels on 27 April. The focus of the competition in 2022 was on cooperative innovations that promote sustainability. At the end of 2021, Atria was the first food company in the world to introduce a carbon footprint label for its chicken products on consumer packaging. The

MapsPeople expands global presence with new sales hub for APAC

MapsPeople A/S | New office in SingaporeMAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. Company Announcement No. 6-2022- Inside Information Aalborg, April 28[th] 2022  MapsPeople expands global presence with a new office in Singapore  In line with the overall strategy, MapsPeople is expanding its international business with a new subsidiary and office in Singapore. The office will serve as the hub office for Asia-Pacific (APAC), and by 2023, the organization is expected to cover all

Ponsse delivered its 200[th] simulator to Sweden

The 200th PONSSE simulator was delivered to Södra Viken, a vocational education centre in Sweden. The simulator model is PONSSE Full, its ergonomics ensure a good training position and make learning meaningful.Ponsse and Södra Viken has worked together over a long time. Södra Viken is a school that has over 70 years of experience in education in the forest industry. First PONSSE machine came to school in 2003. “It is great to see that the forestry school I went to as a young student gets Ponsse´s simulator nr. 200. When sales, service, our premium-products and school cooperation works

Kyoto Group Annual Report 2021

Oslo, 28 April 2022 - Kyoto Group AS (“Kyoto Group”) today published its Annual Report for 2021. The company is fully engaged in executing its growth strategy of becoming the long-term viable provider of thermal energy storage in the Nordic market. Kyoto Group is rapidly developing its service offering to meet the growing industrial demand for heat produced by electricity amid the increasing pressure to phase out fossil fuels and is targeting steep growth already for 2022.  Key events: OPERATIONAL  · Pilot test finalized and converted to R&D test center · New board established

Changes in Terveystalo Executive Team

Terveystalo Plc Stock Exchange Release 28 April 2022 at 9:01 EEST Ilkka Laurila, Chief Financial Officer of Terveystalo, has decided to leave the company. Laurila, who has served as CFO since 2015, will continue in his position until the end of July 2022. The company will immediately launch a recruitment process for a new CFO. Mikko Tainio, Senior Vice President, Public Partnerships, and a member of the Executive Team, has been appointed Terveystalo's Interim CFO and Ville Salmi has been appointed interim SVP of Public Partnerships and a member of the Executive Team as of 1 August 2022.

Alzinova announces positive safety review and continuation of its Phase 1b study in Alzheimer’s disease

Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments for Alzheimer’s disease by specifically targeting neurotoxic amyloid beta oligomers, today announces that the Data and Safety Monitoring Board (DSMB) completed a planned assessment of the ongoing ALZ-101 Phase 1b clinical study and recommended continuation of the study.The DSMB consists of independent group of experts who review data during the study, with particular attention to safety. The data are kept within the DSMB group and may not be revealed to the company, unless action is necessary regarding the

ŠKODA AUTO, Artificial Solutions & Cognizant announce European expansion of Conversational AI Solution

Artificial Solutions ® (SSME: ASAI ) announces today that ŠKODA AUTO is expanding its Conversational AI solution to cover new European regions, taking the total number of countries covered by its chatbot ‘Laura’ to 13. ‘Laura’ is an intelligent chatbot that provides customers with valuable information, helping them in the process of new ŠKODA vehicle selection by advising them which vehicle best fulfills their expectations and requirements and guiding them through the

Aiforia aims to set a new industry standard for customer support with the launch of its one of a kind Aiforia Community Platform

Aiforia Technologies Plc, Press Release, 28 April 2022 at 09.00 a.m. EEST. Earlier this week Aiforia Technologies launched the Aiforia Community Platform — one of the only available platforms of this nature, for pathologists and scientists utilizing AI for image analysis software in preclinical and clinical settings. The company’s users, ranging from some of the world’s largest pharmaceutical companies to the world’s top ranked hospitals and medical institutions, now have free access to the Community Platform.The goal of the Aiforia Community Platform is to bring together the global Aiforia

Conference call in connection with interim report January - March 2022

Analysts, investors and the media are invited to a conference call in connection with the publication of the interim report on Thursday, 12 May at 08:45 CET. The presentation will be held in English. To attend the conference call please register using the link below. After registration you will receive dial in numbers and pin code. Please register here . The presentation material will be published on balder.se 

Ultomiris approved in the US for adults with gMG

28 April 2022 07:00 BST Ultomiris approved in the US for adults with generalised myasthenia gravis First and only long-acting C5 complement inhibitor to demonstrate clinical improvement in patients with generalised myasthenia gravis Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks Ultomiris (ravulizumab-cwvz) has been approved in the US for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive,

There are no items matching the current filter
There are no more items matching the current filter
Back to top